LPCN compared with QNCX: revenue, margins and what each company keeps, and the suppliers and customers both name

LPCNLipocine Inc.

Mkt capRevenueRevenue

QNCXQuince Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

LPCNLipocine Inc.

QNCXQuince Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

LPCNLipocine Inc.

1.46· pre 1.45· delayed

Mkt cap$12.0MRevenue$190,099Q2 FY26Revenue$2MFY25

QNCXQuince Therapeutics, Inc.

33.00· pre 33.00· delayed

Pre-marketNov 3 '26delayed

Mkt cap$34.1MRevenue—Revenue—

Compare

Pre-marketNov 3 '26delayed

LPCNLipocine Inc.

QNCXQuince Therapeutics, Inc.

1.46pre 1.45delayed

Price

33.00pre 33.00delayed

$12.0M

Mkt cap

$34.1M

Q2 FY26$190,099

Revenue

—

FY25$2M

Revenue

—

LPCN1.46vsQNCX33.00Pre-marketNov 3 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

LPCN, solidQNCX, dashed

Supply-chain overlap

Revenue flow

LPCN: latest quarter is a loss; flow not drawable. QNCX: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

No disclosed counterparties: LPCN, QNCX.

Role chip = supplier or customerSource: SEC EDGAR